Citation Impact
Citing Papers
p53: puzzle and paradigm.
1996 Standout
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
2002 StandoutScienceNobel
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes.
1993
Regulation of p53 stability by Mdm2
1997 StandoutNature
Fv1. the mouse retrovirus resistance gene
1998
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
2000 StandoutNobel
WAF1, a potential mediator of p53 tumor suppression
1993 Standout
Minimal Sulfated Carbohydrates for Recognition by L-selectin and the MECA-79 Antibody
2000 StandoutNobel
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
PSF and p54nrb/NonO – multi‐functional nuclear proteins
2002
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Proteasome- and p53-dependent Masking of Signal Transducer and Activator of Transcription (STAT) Factors
1997 StandoutNobel
The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
1998
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008
Immunogenicity of induced pluripotent stem cells
2011 StandoutNature
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
1993 Standout
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
MX2 is an interferon-induced inhibitor of HIV-1 infection
2013 StandoutNatureNobel
Immunity, Inflammation, and Cancer
2010 Standout
Regulation of the p53 Tumor Suppressor Protein
1999
Potent Prostaglandin A1 Analogs That Suppress Tumor Cell Growth through Induction of p21 and Reduction of Cyclin E
1998 StandoutNobel
Phase transitions in the assembly of multivalent signalling proteins
2012 StandoutNature
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 StandoutScience
G1 phase progression: Cycling on cue
1994 Standout
p73 is a human p53-related protein that can induce apoptosis
1997 StandoutNatureNobel
Cancer immunotherapy comes of age
2011 StandoutNature
A model for p53-induced apoptosis
1997 StandoutNature
Principles of CDK regulation
1995 StandoutNature
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
1999 StandoutNature
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
1994 Standout
Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21
1995 StandoutNobel
The tumore suppressor p53
1993
The first 30 years of p53: growing ever more complex
2009 Standout
Anemia of Chronic Disease
2005 Standout
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
2007 StandoutNobel
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.
1992
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
1994 StandoutScience
Dynamic Sorting of Nuclear Components into Distinct Nucleolar Caps during Transcriptional Inhibition
2005
Cancer Cell Cycles
1996 StandoutScience
Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest.
1992
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
1998 StandoutScience
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
2001 StandoutNobel
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
2000
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 Standout
The retinoblastoma protein and cell cycle control
1995 Standout
Surfing the p53 network
2000 StandoutNature
The pathogenesis of cancer metastasis
1980 StandoutNature
Phosphatidylinositol-3-Kinase Signaling Is Required for Erythropoietin-Mediated Acute Protection Against Myocardial Ischemia/Reperfusion Injury
2004 StandoutNobel
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
2003
PERIOD1-Associated Proteins Modulate the Negative Limb of the Mammalian Circadian Oscillator
2005 StandoutScienceNobel
hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
1999 StandoutNobel
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
A cell-surface molecule involved in organ-specific homing of lymphocytes
1983 Nature
Liquid phase condensation in cell physiology and disease
2017 StandoutScience
Immunodepression and Malignancy
1976
Nuclear Relocalization of the Pre-mRNA Splicing Factor PSF during Apoptosis Involves Hyperphosphorylation, Masking of Antigenic Epitopes, and Changes in Protein Interactions
2001
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
2000
Works of Alpha Peled being referenced
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
2001
Increased Circulating Colony-Stimulating Factor-1 (CSF-1) in SJL/J Mice With Radiation-Induced Acute Myeloid Leukemia (AML) Is Associated With Autocrine Regulation of AML Cells by CSF-1
1997
Frequent p53 mutations in chemically induced murine fibrosarcoma.
1991
Immune Status of SJL/J Mice in Relation to Age and Spontaneous Tumor Development2
1973
Role of cytokines in termination of the B cell lymphoma dormant state in AKR mice.
1995
Absence of negative growth regulation in three new murine radiation-induced myeloid leukemia cell lines with deletion of chromosome 2.
1992
Expression of alpha-smooth muscle actin in murine bone marrow stromal cells
1991
A hematopoietic organ-specific 49-kD nuclear antigen: predominance in immature normal and tumor granulocytes and detection in hematopoietic precursor cells
1996
Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form.
1995
Thymus and Bone Marrow Derived Lymphatic Leukaemia in Mice
1973 Nature
Lymphomagenesis in AKR.Fv-1b congenic mice.
1993